Influenza in Nursing Homes

Seasonal influenza is not a mild inconvenience for nursing-home residents. CDC estimates that each year, 70 to 85 percent of seasonal flu-related deaths and 50 to 70 percent of seasonal flu hospitalizations occur in adults aged 65 and older, and hospitalization rates climb steeply with age. Frailty, comorbidity, and congregate living combine in long-term care to produce outbreaks that move fast and hit hard.

Federal law responds to that risk. Under 42 CFR Part 483, every Medicare- and Medicaid-certified nursing home is required to run an infection prevention and control program, offer each resident an influenza immunization every flu season, educate residents or their representatives before offering the vaccine, respect any refusal, and document everything in the medical record. CDC layers onto that framework specific guidance for detecting outbreaks, starting antiviral prophylaxis, and cohorting sick residents. When a facility skips those steps, the result can look a lot like nursing home neglect.

Why Influenza Is Especially Dangerous in Nursing Homes

The nursing-home population is the exact population that flu kills. CDC reports that during the 2024-25 season, which CDC classified as the first high-severity season since 2017-18, adults 65 and older accounted for 57 percent of flu-associated hospitalizations and 71 percent of flu-associated deaths reported through surveillance systems. CDC's total burden estimates for that season were roughly 51 million illnesses, 710,000 hospitalizations, and 45,000 deaths.

The hospitalization curve steepens with each decade of life. CDC's MMWR reported that the cumulative flu hospitalization rate for 2024-25 reached 127.1 per 100,000 overall, the highest rate since 2010-11, while the rate among adults aged 75 and older climbed to 598.8 per 100,000, the second-highest on record for that age group. CDC also notes that hospitalization rates among adults aged 85 and older run two to six times the rate seen among adults 65-74, reflecting the age and frailty profile of many long-term care residents.

Once a resident is sick enough to be hospitalized, the outcomes are sobering. CDC's FluSurv-NET data for 2024-25 showed that 16.8 percent of hospitalized flu patients required ICU admission, 6.1 percent required invasive mechanical ventilation, and 3.0 percent died in the hospital. Those are national figures across all ages; older adults carry the bulk of the severe cases.

Federal Vaccination Requirement: 42 CFR Section 483.80(d)

The core federal rule for flu vaccination in nursing homes is 42 CFR Section 483.80(d). It is not optional, and it is not a suggestion. Every Medicare- and Medicaid-certified long-term care facility must develop policies and procedures to ensure that each resident is offered an influenza immunization October 1 through March 31 annually, unless the resident was already immunized that season or the vaccine is medically contraindicated.

Education before the offer

Section 483.80(d)(1)(i) requires that before offering the flu shot, each resident or the resident's representative receives education regarding the benefits and potential side effects of the immunization. Education is not a formality. It is a prerequisite, and skipping it is itself a deficiency a surveyor can cite.

The right to refuse

Section 483.80(d)(1)(iii) requires that the resident or the resident's representative has the opportunity to refuse immunization. Refusal must be accepted. Coerced vaccination is not compliant with federal rules, and families should never be told that their loved one 'has to' take the vaccine. The facility's job is to offer, educate, and document, not to override the resident's decision.

Documentation in the medical record

Section 483.80(d)(1)(iv) requires the resident's medical record to document that education was provided and that the resident either received the immunization or did not receive it due to medical contraindication or refusal. Missing documentation is itself a survey deficiency, even if the facility later claims the vaccine was offered. In practice, if it is not in the chart, it did not happen.

The parallel pneumococcal requirement

Section 483.80(d)(2) creates a mirror requirement for pneumococcal vaccination, with the same education, offer, refusal, and documentation obligations. That pairing is not administrative housekeeping. Secondary bacterial pneumonia, especially from Streptococcus pneumoniae and Staphylococcus aureus, is a well-documented complication of influenza in older adults, and peer-reviewed analyses report that bacterial co-infection increases mortality risk in hospitalized flu patients roughly 2.6 to 3.4 fold compared with flu alone.

CMS Survey Enforcement Through F-Tag F883

CMS turns 42 CFR Section 483.80(d) into an enforceable survey citation through F-tag F883, titled 'Influenza and Pneumococcal Immunizations.' When state surveyors inspect a nursing home, they review resident records for evidence of screening, education, administration or refusal, and tracking of vaccination status across the resident census. A facility that cannot produce that documentation can be cited under F883 for both its flu and pneumococcal programs.

F883 deficiencies can arise in several ways. A facility may fail to offer the vaccine at all. It may offer the vaccine without first educating the resident or representative. It may administer the vaccine without recording consent or documenting a refusal. Or it may fail to track which residents on the current census still need to be offered the vaccine during the October-through-March window. Each of these is a federal failure, and a pattern of them can escalate to broader infection-control findings under 42 CFR Section 483.80.

Higher-Dose and Adjuvanted Vaccines for Adults 65 and Older

Not every flu vaccine is the same for older adults. The Advisory Committee on Immunization Practices, or ACIP, recommends that adults aged 65 and older preferentially receive one of three enhanced products: high-dose inactivated influenza vaccine (HD-IIV), recombinant influenza vaccine (RIV), or adjuvanted inactivated influenza vaccine (aIIV). If none of those three are available, ACIP states that any age-appropriate flu vaccine should be used rather than delaying vaccination.

The rationale is immunologic. CDC explains that the high-dose inactivated vaccine (marketed as Fluzone High-Dose) contains four times the antigen of standard-dose flu vaccine and is licensed for adults 65 and older. A pivotal randomized trial published in the New England Journal of Medicine found that Fluzone High-Dose was approximately 24 percent more effective than standard-dose flu vaccine at preventing laboratory-confirmed influenza in adults 65 and older.

The adjuvanted product (Fluad) uses an MF59 adjuvant to boost the immune response in older adults. CDC cites a cluster-randomized study in nursing-home residents aged 65 and older that found Fluad was associated with a lower risk of hospitalization for pneumonia and influenza compared with standard-dose flu vaccine. Families asking a facility which vaccine a loved one received, and why, are asking a reasonable and federally relevant question.

Vaccination Coverage Gaps: Residents and Staff

The federal rule requires facilities to offer the vaccine. The real-world data shows that coverage is slipping. CDC's National Healthcare Safety Network (NHSN) data published in MMWR show that influenza vaccination coverage among nursing-home residents fell from 68.3 percent in November 2023 to 58.4 percent in November 2024, a 9.9 percentage-point decrease. The reporting sample covered 8,974 of 15,100 CMS-certified nursing homes, or 59.4 percent of the industry, and coverage varied by HHS region from 50.9 percent in Region 10 to 64.1 percent in Region 1.

Healthcare personnel coverage in nursing homes is even lower. CDC NHSN data show that influenza vaccination coverage among healthcare personnel was 45.4 percent in nursing-home settings during the 2023-24 respiratory virus season, compared with 75.4 percent overall HCP coverage across all healthcare settings that season. Unvaccinated staff are an ongoing transmission risk: CDC guidance for healthcare settings states that annual influenza vaccination is the most important measure to prevent seasonal influenza infection, and CDC recommends annual vaccination of all healthcare personnel as a patient-safety measure.

There is no nationwide federal mandate that every individual nursing-home worker must be vaccinated against seasonal flu, though state rules vary and CDC collects HCP vaccination data through NHSN. What the federal rules do require is an operating infection prevention and control program under Section 483.80, and chronic undervaccination of staff is a structural weakness in that program. Flu-season staffing gaps are also part of why nursing home understaffing sits next to infection control as a core neglect concern.

Outbreak Definition and Rapid Response

CDC does not leave long-term care facilities to guess when an outbreak begins. CDC's Viral Respiratory Pathogens Toolkit for Nursing Homes states that a facility should initiate antiviral chemoprophylaxis for exposed residents when at least 2 residents are ill within 72 hours of each other and at least one resident has laboratory-confirmed influenza. That is the operational trigger, and it is low on purpose. Waiting for more cases means waiting for more residents to get sick.

CDC defines influenza-like illness (ILI) as fever of 100 degrees Fahrenheit (37.8 degrees Celsius) or greater with cough and/or sore throat. Facilities typically use ILI criteria to flag residents for testing and to count cases against the outbreak threshold. Once the threshold is met, CDC's toolkit expects facilities to:

• Conduct daily or every-shift symptom review of residents and staff during respiratory virus season.
• Test residents and staff with new respiratory symptoms (CDC recommends multiplex flu/SARS-CoV-2 assays).
• Keep symptomatic residents in their rooms and cohort confirmed cases together on designated units.
• Dedicate staff to cohort units to reduce cross-transmission between well and sick residents.
• Use droplet precautions for residents with suspected or confirmed influenza for 7 days after illness onset or until 24 hours after resolution of fever, whichever is longer, plus source-control masking for symptomatic residents who must leave their rooms.

Peer-reviewed case series in CDC's Emerging Infectious Diseases journal have documented flu outbreaks in long-term care facilities, including outbreaks involving antiviral-resistant virus, with attack rates and mortality that underscore the importance of rapid detection, testing, isolation, and prompt chemoprophylaxis. The toolkit steps above are what that literature turns into daily practice.

Antiviral Chemoprophylaxis and Early Treatment

Chemoprophylaxis is the preventive use of an influenza antiviral in a person who is not yet sick. During a confirmed flu outbreak in a long-term care facility, CDC recommends chemoprophylaxis for all exposed residents on affected units, including residents who have already received the flu vaccine that season. Vaccine protection is not complete, especially in frail older adults, and prophylaxis is the second layer of defense.

CDC recommends that antiviral chemoprophylaxis of non-ill residents on affected units run for a minimum of 2 weeks and continue for at least 1 week after the last known case is identified. Oseltamivir is the standard agent; CDC's clinician summary lists standard oral oseltamivir chemoprophylaxis dosing for adults at 75 mg once daily, with adjustment for renal function. The four FDA-approved influenza antivirals CDC recommends are oseltamivir (oral), zanamivir (inhaled), peramivir (IV), and baloxavir (oral).

Early antiviral treatment matters just as much for residents who do become ill. CDC states that clinical benefit is greatest when antiviral treatment is administered early, especially within 48 hours of influenza illness onset. Delayed recognition of a symptomatic resident, whether from thin staffing, missed symptom checks, or dismissal of atypical presentations in older adults, can foreclose that window entirely.

Warning Signs Families Can Recognize

Flu in an older adult does not always look like flu in a younger adult. Textbook symptoms such as high fever, body aches, and cough can be muted or absent in frail residents. CDC's ILI case definition is fever of 100 degrees Fahrenheit or greater with cough and/or sore throat, but facilities caring for elders should watch for a wider set of changes.

• New or worsening confusion, lethargy, or withdrawal from normal activities.
• Low-grade fever, chills, or a new cough that was not present a day earlier.
• Sudden functional decline, new falls, or inability to get out of bed.
• Shortness of breath, rapid breathing, or reduced oxygen saturation reported by the nurse.
• A cluster of similar symptoms among multiple residents on the same hallway within a few days.

Families who notice any of these changes should ask whether the resident has been tested for influenza, whether the facility has started an outbreak investigation, and whether antiviral treatment has been considered within the 48-hour window. These are not interrogations. They are the same questions CDC expects an infection preventionist to be asking every shift.

Post-Influenza Complications in Older Adults

Influenza in an older adult is rarely just a respiratory virus. Peer-reviewed literature documents that secondary bacterial pneumonia, particularly from Streptococcus pneumoniae and Staphylococcus aureus, is a principal complication of influenza and a major driver of influenza-associated mortality in older adults. Flu damages the respiratory epithelium and immune defenses, and bacterial pathogens move in. That is why the federal pneumococcal vaccination requirement in Section 483.80(d)(2) sits next to the flu rule.

Pneumonia is not the only downstream concern. Severe or untreated flu can progress to sepsis, hospitalization, and functional decline that the resident never fully recovers from. Broader respiratory infections in long-term care share many of the same risk factors and warning signs.

When Flu Failures Look Like Neglect

Influenza itself is not neglect. Flu is a seasonal virus, and even a well-run facility can see cases. What separates a compliant response from a neglect concern is the pattern of decisions around the virus. A facility that fails to offer the vaccine, skips the required education, cannot produce documentation of refusals, ignores early ILI symptoms in residents, delays testing, or waits past the CDC outbreak trigger to begin antiviral chemoprophylaxis is not just unlucky. It is out of step with the federal infection-control framework under 42 CFR Section 483.80.

Under the Nursing Home Reform Act and 42 CFR Part 483, residents have the right to a safe environment and to an infection prevention and control program that is actually operating. When infection-control failures contribute to harm, families can raise those concerns through the state survey agency, the Long-Term Care Ombudsman, and, in cases involving death, a referral can overlap with wrongful death analysis. Broader concerns about abuse or neglect outside the infection-control context are covered in our nursing home abuse resources.

What Families Should Do During Flu Season

Families do not need to be infection-control clinicians to advocate for a nursing-home resident during flu season. A short list of questions maps directly onto the federal rules described above.

• Has my loved one been offered a flu vaccine this season? Which vaccine (high-dose, adjuvanted, or recombinant)?
• Was the required education about benefits and side effects provided before the offer, and is that documented?
• What is the facility doing to vaccinate staff, and what is the facility's current HCP vaccination rate?
• Is there an active outbreak on this unit? If so, when did it start and when was antiviral chemoprophylaxis initiated?
• If my loved one develops symptoms, how quickly will they be tested, and who will call me?

If the answers are evasive or if documentation is missing, concerns can be filed with the state survey agency, which investigates F-tag deficiencies including F883, and with the Long-Term Care Ombudsman. State-specific reporting pathways are outlined in our New York nursing home complaint guide, Massachusetts nursing home complaint guide, and Washington nursing home complaint guide.

If harm has already occurred and families want to understand legal options outside of the regulatory reporting system, they can also speak with an attorney about a separate civil review. That conversation is independent of the federal reporting channels described above.